Feedback
Epithelial Basement Membrane Zone Antibody IgA
0092057
Ordering Recommendation

• Assess and monitor patients with positive IgA BMZ antibodies, either epidermal (roof) pattern or dermal (floor) pattern, in linear IgA disease, including linear IgA bullous dermatosis and chronic bullous disease of childhood, IgA variant epidermolysis bullosa acquisita (EBA), and overlap expression in pemphigoid with IgG basement membrane zone (BMZ) antibodies. 
• Consider ordering concurrently with Epithelial Basement Membrane Zone Antibody IgG (0092056), Bullous Pemphigoid Antigens (180 kDa and 230 kDa), IgG (0092566), and/or Collagen Type VII Antibody IgG by ELISA (2010905); alternatively, order Basement Membrane Zone Antibody Panel (3001410).

Mnemonic
EBMZ IGA
Methodology
Indirect Immunofluorescence
(Indirect Fluorescent Antibody)
Performed
Varies
Reported
4-9 days
New York DOH Approval Status
This test is New York DOH approved.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Plain red or serum separator tube (SST). 
Specimen Preparation
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Hemolyzed or lipemic specimens. 
Remarks
 
Stability
Ambient: 1 week; Refrigerated: 2 weeks; Frozen: Indefinitely 
Reference Interval
By report
Interpretive Data


Note
For specimens less than 0.5 mL, call the Immunodermatology Laboratory at (866) 266-5699.
Hotline History
View Hotline History
Components
Component Test Code*Component Chart NameLOINC
0092057Epithelial BMZ Ab, IgA
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases